Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults With a Fontan Circulation.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
02 03 2021
Historique:
pubmed: 25 11 2020
medline: 4 1 2022
entrez: 24 11 2020
Statut: ppublish

Résumé

Neurocognitive outcomes beyond childhood in people with a Fontan circulation are not well defined. This study aimed to investigate neurocognitive functioning in adolescents and adults with a Fontan circulation and associations with structural brain injury, brain volumetry, and postnatal clinical factors. In a binational study, participants with a Fontan circulation without a preexisting major neurological disability were prospectively recruited from the Australia and New Zealand Fontan Registry. Neurocognitive function was assessed by using Cogstate software in 107 participants with a Fontan circulation and compared with control groups with transposition of the great arteries (n=50) and a normal circulation (n=41). Brain MRI with volumetric analysis was performed in the participants with a Fontan circulation and compared with healthy control data from the ABIDE I and II (Autism Brain Imaging Data Exchange) and PING (Pediatric Imaging, Neurocognition, and Genetics) data repositories. Clinical data were retrospectively collected. Of the participants with a Fontan circulation who had a neurocognitive assessment, 55% were male and the mean age was 22.6 years (SD 7.8). Participants with a Fontan circulation performed worse in several areas of neurocognitive function compared with those with transposition of the great arteries and healthy controls ( Neurocognitive impairment is common in adolescents and adults with a Fontan circulation and is associated with smaller gray and white matter brain volume. Understanding modifiable factors that contribute to brain injury to optimize neurocognitive function is paramount.

Sections du résumé

BACKGROUND
Neurocognitive outcomes beyond childhood in people with a Fontan circulation are not well defined. This study aimed to investigate neurocognitive functioning in adolescents and adults with a Fontan circulation and associations with structural brain injury, brain volumetry, and postnatal clinical factors.
METHODS
In a binational study, participants with a Fontan circulation without a preexisting major neurological disability were prospectively recruited from the Australia and New Zealand Fontan Registry. Neurocognitive function was assessed by using Cogstate software in 107 participants with a Fontan circulation and compared with control groups with transposition of the great arteries (n=50) and a normal circulation (n=41). Brain MRI with volumetric analysis was performed in the participants with a Fontan circulation and compared with healthy control data from the ABIDE I and II (Autism Brain Imaging Data Exchange) and PING (Pediatric Imaging, Neurocognition, and Genetics) data repositories. Clinical data were retrospectively collected.
RESULTS
Of the participants with a Fontan circulation who had a neurocognitive assessment, 55% were male and the mean age was 22.6 years (SD 7.8). Participants with a Fontan circulation performed worse in several areas of neurocognitive function compared with those with transposition of the great arteries and healthy controls (
CONCLUSIONS
Neurocognitive impairment is common in adolescents and adults with a Fontan circulation and is associated with smaller gray and white matter brain volume. Understanding modifiable factors that contribute to brain injury to optimize neurocognitive function is paramount.

Identifiants

pubmed: 33231097
doi: 10.1161/CIRCULATIONAHA.120.048202
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

878-891

Subventions

Organisme : NIDA NIH HHS
ID : RC2 DA029475
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Charlotte E Verrall (CE)

Heart Centre for Children (C.E.V., J.A., D.S.W.), The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.

Joseph Y M Yang (JYM)

Neuroscience Advanced Clinical Imaging Suite (NACIS), Department of Neurosurgery (J.Y.M.Y.), The Royal Children's Hospital, Melbourne, Victoria, Australia.
Developmental Imaging (J.Y.M.Y., J.C.), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Jian Chen (J)

Developmental Imaging (J.Y.M.Y., J.C.), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Stuart M Grieve (SM)

Sydney Translational Imaging Laboratory, Charles Perkins Centre, Faculty of Medicine and Health (S.M.G., T.W.), University of Sydney, New South Wales, Australia.

Thomas Welton (T)

Sydney Translational Imaging Laboratory, Charles Perkins Centre, Faculty of Medicine and Health (S.M.G., T.W.), University of Sydney, New South Wales, Australia.

Belinda Barton (B)

Children's Hospital Education Research Institute and Kids Neuroscience Centre (B.B.), The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

David S Celermajer (DS)

Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.

Julian Ayer (J)

Heart Centre for Children (C.E.V., J.A., D.S.W.), The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.

Simone Mandelstam (S)

Department of Cardiac Surgery (Y.d'U.), Medical Imaging (S.M.), The Royal Children's Hospital, Melbourne, Victoria, Australia.

David S Winlaw (DS)

Heart Centre for Children (C.E.V., J.A., D.S.W.), The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.

Mark T Mackay (MT)

Department of Neurology (M.T.M.), The Royal Children's Hospital, Melbourne, Victoria, Australia.

Rachael Cordina (R)

Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH